Literature DB >> 7076295

Protection in rabbits induced by the Texas Star-SR attenuated A-B+ mutant candidate live oral cholera vaccine.

M Boesman-Finkelstein, R A Finkelstein.   

Abstract

The avirulent, A-B+, streptomycin-resistant mutant designated Texas Star-SR, isolated from a virulent, hypertoxinogenic, colonizing strain of Vibrio cholerae (Ogawa serotype, El Tor biotype) and administered intragastrically or intraduodenally in adult rabbits, has been found to induce substantial immunity to subsequent challenge (in ligated intestinal loops) with virulent wild-type cholera vibrios (of both homologous and heterologous biotype and serotype). Significant resistance to challenge with one strain of human heat-labile enterotoxin (LT)-producing Escherichia coli was also demonstrated, but resistance against two other human LT-producing strains was either nil or marginal under these experimental conditions. Significant, but not striking, resistance against challenge with purified choleragen was obtained, whereas protection against a bolus challenge of purified porcine LT was not statistically significant.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7076295      PMCID: PMC351207          DOI: 10.1128/iai.36.1.221-226.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Selection and characteristics of a Vibrio cholerae mutant lacking the A (ADP-ribosylating) portion of the cholera enterotoxin.

Authors:  T Honda; R A Finkelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

2.  Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid.

Authors:  A M Svennerholm; J Holmgren
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

3.  Immunological cross-reactivity between a heat-labile enterotoxin(s) of Escherichia coli and subunits of Vibrio cholerae enterotoxin.

Authors:  J D Clements; R A Finkelstein
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

4.  Deactivation of cholera toxin by a sialidase-resistant monosialosylganglioside.

Authors:  C A King; W E Van Heyningen
Journal:  J Infect Dis       Date:  1973-06       Impact factor: 5.226

5.  A serological survey for cholear antibodies in rural east Pakistan. 1. The distribution of antibody in the control population of a cholera-vaccine field-trial area and the relation of antibody titre to the pattern of endemic cholera.

Authors:  W H Mosley; A S Benenson; R Barui
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

6.  Properties of homogeneous heat-labile enterotoxin from Escherichia coli.

Authors:  J D Clements; R J Yancey; R A Finkelstein
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

7.  Duration of infection-derived immunity to cholera.

Authors:  M M Levine; R E Black; M L Clements; L Cisneros; D R Nalin; C R Young
Journal:  J Infect Dis       Date:  1981-06       Impact factor: 5.226

8.  Flagella-induced immunity against experimental cholera in adult rabbits.

Authors:  R J Yancey; D L Willis; L J Berry
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

9.  Comparison of heat-labile enterotoxins from porcine and human strains of Escherichia coli.

Authors:  S J Geary; B A Marchlewicz; R A Finkelstein
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

10.  Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid.

Authors:  R A Finkelstein; J J LoSpalluto
Journal:  J Exp Med       Date:  1969-07-01       Impact factor: 14.307

View more
  10 in total

1.  Competitive enzyme-linked immunosorbent assay for cholera-related enterotoxins in Salmonella typhimurium.

Authors:  H Hariharan; B A Booth; T J Brickman; W C Katt; M Boesman-Finkelstein; R A Finkelstein
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

2.  Vibrio cholerae hemagglutinin/lectin/protease hydrolyzes fibronectin and ovomucin: F.M. Burnet revisited.

Authors:  R A Finkelstein; M Boesman-Finkelstein; P Holt
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

3.  Successful colonization and immunization of adult rabbits by oral inoculation with Vibrio cholerae O1.

Authors:  W C Cray; E Tokunaga; N F Pierce
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

4.  Compared colonizing and immunizing efficiency of toxinogenic (A+ B+) Vibrio cholerae and an A- B+ mutant (Texas Star-SR) studied in adult rabbits.

Authors:  E Tokunaga; W C Cray; N F Pierce
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

5.  Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine.

Authors:  M M Levine; R E Black; M L Clements; C Lanata; S Sears; T Honda; C R Young; R A Finkelstein
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

6.  Immunizing adult female mice with a TcpA-A2-CTB chimera provides a high level of protection for their pups in the infant mouse model of cholera.

Authors:  Gregory A Price; Randall K Holmes
Journal:  PLoS Negl Trop Dis       Date:  2014-12-04

7.  Differences in cross-protection in rats immunized with the B subunits of cholera toxin and Escherichia coli heat-labile toxin.

Authors:  F A Klipstein; R F Engert; J D Clements; R A Houghten
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

8.  Construction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli-related diarrheas.

Authors:  J D Clements; S El-Morshidy
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

9.  Immunological relationships between cholera toxin and Escherichia coli heat-labile enterotoxin.

Authors:  P H Gilligan; J C Brown; D C Robertson
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

10.  Oral immunization of mice with attenuated Salmonella enteritidis containing a recombinant plasmid which codes for production of the B subunit of heat-labile Escherichia coli enterotoxin.

Authors:  J D Clements; F L Lyon; K L Lowe; A L Farrand; S el-Morshidy
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.